How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Sell
49
MD Quote, Financials, Valuation and Earnings
Last price:
$12.13
Seasonality move
:
8.07%
Day range:
$11.94 - $12.79
52-week range:
$6.62 - $17.67
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.50x
P/B ratio:
1.35x
Volume:
451.2K
Avg. volume:
698.9K
1-year change:
32.89%
Market cap:
$1B
Revenue:
$2B
EPS (TTM):
-$1.21
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
MD
Pediatrix Medical Group
|
$451.4M | $0.24 | -8.82% | 382.8% | $18.07 |
|
CON
Concentra Group Holdings Parent
|
$496.1M | $0.32 | 6.09% | 12.69% | $27.88 |
|
EHC
Encompass Health
|
$1.4B | $1.19 | 8.88% | 9.22% | $117.18 |
|
KDLY
Kindly MD
|
-- | -- | -- | -- | -- |
|
TOI
The Oncology Institute
|
$103.3M | -$0.10 | 27.72% | -52.63% | -- |
|
USPH
US Physical Therapy
|
$176.8M | $0.45 | 13.56% | -1.79% | $108.33 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
MD
Pediatrix Medical Group
|
$12.00 | $18.07 | $1B | -- | $0.00 | 0% | 0.50x |
|
CON
Concentra Group Holdings Parent
|
$19.83 | $27.88 | $2.5B | 16.14x | $0.06 | 0% | 1.31x |
|
EHC
Encompass Health
|
$96.12 | $117.18 | $9.7B | 21.55x | $0.17 | 0.69% | 1.83x |
|
KDLY
Kindly MD
|
$1.47 | -- | $8.8M | -- | $0.00 | 0% | 3.09x |
|
TOI
The Oncology Institute
|
$2.39 | -- | $209.7M | -- | $0.00 | 0% | 0.46x |
|
USPH
US Physical Therapy
|
$66.31 | $108.33 | $1B | 36.04x | $0.45 | 2.67% | 1.49x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
MD
Pediatrix Medical Group
|
44.46% | 1.472 | 54.35% | 1.43x |
|
CON
Concentra Group Holdings Parent
|
100% | 0.000 | 57.83% | 1.31x |
|
EHC
Encompass Health
|
54.72% | 0.495 | 24.76% | 0.81x |
|
KDLY
Kindly MD
|
5.14% | 0.000 | 3% | 5.08x |
|
TOI
The Oncology Institute
|
96.29% | -2.763 | 397.95% | 1.88x |
|
USPH
US Physical Therapy
|
23.9% | 1.776 | 9.54% | 1.09x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
MD
Pediatrix Medical Group
|
$128.5M | $58.1M | -6.97% | -12.67% | 8.57% | $129.6M |
|
CON
Concentra Group Holdings Parent
|
$120.2M | $59.1M | 13.96% | 23.06% | 12.71% | $77M |
|
EHC
Encompass Health
|
$585.9M | $232.3M | 8.76% | 17.79% | 16.68% | $80.1M |
|
KDLY
Kindly MD
|
$640.1K | -$1M | -137.75% | -201.03% | -155.05% | -$1M |
|
TOI
The Oncology Institute
|
$14.6M | -$11.9M | -54.21% | -220.55% | -11.98% | $2.4M |
|
USPH
US Physical Therapy
|
$32.5M | $17M | 3.18% | 3.86% | 11.29% | $16.9M |
Pediatrix Medical Group vs. Competitors
-
Which has Higher Returns MD or CON?
Concentra Group Holdings Parent has a net margin of 6.07% compared to Pediatrix Medical Group's net margin of 4.63%. Pediatrix Medical Group's return on equity of -12.67% beat Concentra Group Holdings Parent's return on equity of 23.06%.
Company Gross Margin Earnings Per Share Invested Capital MDPediatrix Medical Group25.58% $0.35 $1.4B CONConcentra Group Holdings Parent25.85% $0.17 $1.5B -
What do Analysts Say About MD or CON?
Pediatrix Medical Group has a consensus price target of $18.07, signalling upside risk potential of 50.6%. On the other hand Concentra Group Holdings Parent has an analysts' consensus of $27.88 which suggests that it could grow by 40.57%. Given that Pediatrix Medical Group has higher upside potential than Concentra Group Holdings Parent, analysts believe Pediatrix Medical Group is more attractive than Concentra Group Holdings Parent.
Company Buy Ratings Hold Ratings Sell Ratings MDPediatrix Medical Group3 5 0 CONConcentra Group Holdings Parent5 0 0 -
Is MD or CON More Risky?
Pediatrix Medical Group has a beta of 1.325, which suggesting that the stock is 32.466% more volatile than S&P 500. In comparison Concentra Group Holdings Parent has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MD or CON?
Pediatrix Medical Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Concentra Group Holdings Parent offers a yield of 0% to investors and pays a quarterly dividend of $0.06 per share. Pediatrix Medical Group pays -- of its earnings as a dividend. Concentra Group Holdings Parent pays out 926.87% of its earnings as a dividend.
-
Which has Better Financial Ratios MD or CON?
Pediatrix Medical Group quarterly revenues are $502.4M, which are larger than Concentra Group Holdings Parent quarterly revenues of $465M. Pediatrix Medical Group's net income of $30.5M is higher than Concentra Group Holdings Parent's net income of $21.5M. Notably, Pediatrix Medical Group's price-to-earnings ratio is -- while Concentra Group Holdings Parent's PE ratio is 16.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group is 0.50x versus 1.31x for Concentra Group Holdings Parent. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDPediatrix Medical Group0.50x -- $502.4M $30.5M CONConcentra Group Holdings Parent1.31x 16.14x $465M $21.5M
-
Which has Higher Returns MD or EHC?
Encompass Health has a net margin of 6.07% compared to Pediatrix Medical Group's net margin of 8.61%. Pediatrix Medical Group's return on equity of -12.67% beat Encompass Health's return on equity of 17.79%.
Company Gross Margin Earnings Per Share Invested Capital MDPediatrix Medical Group25.58% $0.35 $1.4B EHCEncompass Health41.7% $1.18 $5.3B -
What do Analysts Say About MD or EHC?
Pediatrix Medical Group has a consensus price target of $18.07, signalling upside risk potential of 50.6%. On the other hand Encompass Health has an analysts' consensus of $117.18 which suggests that it could grow by 21.91%. Given that Pediatrix Medical Group has higher upside potential than Encompass Health, analysts believe Pediatrix Medical Group is more attractive than Encompass Health.
Company Buy Ratings Hold Ratings Sell Ratings MDPediatrix Medical Group3 5 0 EHCEncompass Health10 0 0 -
Is MD or EHC More Risky?
Pediatrix Medical Group has a beta of 1.325, which suggesting that the stock is 32.466% more volatile than S&P 500. In comparison Encompass Health has a beta of 0.882, suggesting its less volatile than the S&P 500 by 11.77%.
-
Which is a Better Dividend Stock MD or EHC?
Pediatrix Medical Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Encompass Health offers a yield of 0.69% to investors and pays a quarterly dividend of $0.17 per share. Pediatrix Medical Group pays -- of its earnings as a dividend. Encompass Health pays out 13.78% of its earnings as a dividend. Encompass Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios MD or EHC?
Pediatrix Medical Group quarterly revenues are $502.4M, which are smaller than Encompass Health quarterly revenues of $1.4B. Pediatrix Medical Group's net income of $30.5M is lower than Encompass Health's net income of $120.9M. Notably, Pediatrix Medical Group's price-to-earnings ratio is -- while Encompass Health's PE ratio is 21.55x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group is 0.50x versus 1.83x for Encompass Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDPediatrix Medical Group0.50x -- $502.4M $30.5M EHCEncompass Health1.83x 21.55x $1.4B $120.9M
-
Which has Higher Returns MD or KDLY?
Kindly MD has a net margin of 6.07% compared to Pediatrix Medical Group's net margin of -156.54%. Pediatrix Medical Group's return on equity of -12.67% beat Kindly MD's return on equity of -201.03%.
Company Gross Margin Earnings Per Share Invested Capital MDPediatrix Medical Group25.58% $0.35 $1.4B KDLYKindly MD98.8% -$0.17 $3.7M -
What do Analysts Say About MD or KDLY?
Pediatrix Medical Group has a consensus price target of $18.07, signalling upside risk potential of 50.6%. On the other hand Kindly MD has an analysts' consensus of -- which suggests that it could fall by --. Given that Pediatrix Medical Group has higher upside potential than Kindly MD, analysts believe Pediatrix Medical Group is more attractive than Kindly MD.
Company Buy Ratings Hold Ratings Sell Ratings MDPediatrix Medical Group3 5 0 KDLYKindly MD0 0 0 -
Is MD or KDLY More Risky?
Pediatrix Medical Group has a beta of 1.325, which suggesting that the stock is 32.466% more volatile than S&P 500. In comparison Kindly MD has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MD or KDLY?
Pediatrix Medical Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Kindly MD offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pediatrix Medical Group pays -- of its earnings as a dividend. Kindly MD pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MD or KDLY?
Pediatrix Medical Group quarterly revenues are $502.4M, which are larger than Kindly MD quarterly revenues of $647.9K. Pediatrix Medical Group's net income of $30.5M is higher than Kindly MD's net income of -$1M. Notably, Pediatrix Medical Group's price-to-earnings ratio is -- while Kindly MD's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group is 0.50x versus 3.09x for Kindly MD. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDPediatrix Medical Group0.50x -- $502.4M $30.5M KDLYKindly MD3.09x -- $647.9K -$1M
-
Which has Higher Returns MD or TOI?
The Oncology Institute has a net margin of 6.07% compared to Pediatrix Medical Group's net margin of -13.15%. Pediatrix Medical Group's return on equity of -12.67% beat The Oncology Institute's return on equity of -220.55%.
Company Gross Margin Earnings Per Share Invested Capital MDPediatrix Medical Group25.58% $0.35 $1.4B TOIThe Oncology Institute14.6% -$0.14 $96.7M -
What do Analysts Say About MD or TOI?
Pediatrix Medical Group has a consensus price target of $18.07, signalling upside risk potential of 50.6%. On the other hand The Oncology Institute has an analysts' consensus of -- which suggests that it could fall by -16.32%. Given that Pediatrix Medical Group has higher upside potential than The Oncology Institute, analysts believe Pediatrix Medical Group is more attractive than The Oncology Institute.
Company Buy Ratings Hold Ratings Sell Ratings MDPediatrix Medical Group3 5 0 TOIThe Oncology Institute0 0 0 -
Is MD or TOI More Risky?
Pediatrix Medical Group has a beta of 1.325, which suggesting that the stock is 32.466% more volatile than S&P 500. In comparison The Oncology Institute has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock MD or TOI?
Pediatrix Medical Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Oncology Institute offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Pediatrix Medical Group pays -- of its earnings as a dividend. The Oncology Institute pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios MD or TOI?
Pediatrix Medical Group quarterly revenues are $502.4M, which are larger than The Oncology Institute quarterly revenues of $100.3M. Pediatrix Medical Group's net income of $30.5M is higher than The Oncology Institute's net income of -$13.2M. Notably, Pediatrix Medical Group's price-to-earnings ratio is -- while The Oncology Institute's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group is 0.50x versus 0.46x for The Oncology Institute. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDPediatrix Medical Group0.50x -- $502.4M $30.5M TOIThe Oncology Institute0.46x -- $100.3M -$13.2M
-
Which has Higher Returns MD or USPH?
US Physical Therapy has a net margin of 6.07% compared to Pediatrix Medical Group's net margin of 4.12%. Pediatrix Medical Group's return on equity of -12.67% beat US Physical Therapy's return on equity of 3.86%.
Company Gross Margin Earnings Per Share Invested Capital MDPediatrix Medical Group25.58% $0.35 $1.4B USPHUS Physical Therapy18.03% $0.52 $912.6M -
What do Analysts Say About MD or USPH?
Pediatrix Medical Group has a consensus price target of $18.07, signalling upside risk potential of 50.6%. On the other hand US Physical Therapy has an analysts' consensus of $108.33 which suggests that it could grow by 63.37%. Given that US Physical Therapy has higher upside potential than Pediatrix Medical Group, analysts believe US Physical Therapy is more attractive than Pediatrix Medical Group.
Company Buy Ratings Hold Ratings Sell Ratings MDPediatrix Medical Group3 5 0 USPHUS Physical Therapy2 1 0 -
Is MD or USPH More Risky?
Pediatrix Medical Group has a beta of 1.325, which suggesting that the stock is 32.466% more volatile than S&P 500. In comparison US Physical Therapy has a beta of 1.376, suggesting its more volatile than the S&P 500 by 37.634%.
-
Which is a Better Dividend Stock MD or USPH?
Pediatrix Medical Group has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. US Physical Therapy offers a yield of 2.67% to investors and pays a quarterly dividend of $0.45 per share. Pediatrix Medical Group pays -- of its earnings as a dividend. US Physical Therapy pays out 100.3% of its earnings as a dividend.
-
Which has Better Financial Ratios MD or USPH?
Pediatrix Medical Group quarterly revenues are $502.4M, which are larger than US Physical Therapy quarterly revenues of $180.4M. Pediatrix Medical Group's net income of $30.5M is higher than US Physical Therapy's net income of $7.4M. Notably, Pediatrix Medical Group's price-to-earnings ratio is -- while US Physical Therapy's PE ratio is 36.04x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Pediatrix Medical Group is 0.50x versus 1.49x for US Physical Therapy. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income MDPediatrix Medical Group0.50x -- $502.4M $30.5M USPHUS Physical Therapy1.49x 36.04x $180.4M $7.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
58
AGX alert for Apr 22
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
